Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Buy
59
ENGN Quote, Financials, Valuation and Earnings
Last price:
$8.76
Seasonality move
:
17.26%
Day range:
$8.39 - $9.20
52-week range:
$2.65 - $11.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.52x
Volume:
446.1K
Avg. volume:
260.5K
1-year change:
8.77%
Market cap:
$590.1M
Revenue:
--
EPS (TTM):
-$2.29
Analysts' Opinion
-
Consensus RatingenGene Holdings, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $23.50, enGene Holdings, Inc. has an estimated upside of 166.74% from its current price of $8.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $8.81.
Fair Value
-
According to the consensus of 7 analysts, enGene Holdings, Inc. has 166.74% upside to fair value with a price target of $23.50 per share.
ENGN vs. S&P 500
-
Over the past 5 trading days, enGene Holdings, Inc. has underperformed the S&P 500 by -1.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
enGene Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
enGene Holdings, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter enGene Holdings, Inc. reported revenues of --.
Earnings Growth
-
enGene Holdings, Inc. earnings have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter enGene Holdings, Inc. reported earnings per share of -$0.74.
Enterprise value:
428.1M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-4.25x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$509K
Return On Assets:
-44.07%
Net Income Margin (TTM):
--
Return On Equity:
-52.45%
Return On Invested Capital:
-46.66%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -$323K | -$509K | -$83K | -$171K | |
| Operating Income | -$26.1M | -$62.3M | -$123.2M | -$17.5M | -$39.5M | |
| EBITDA | -$94.8M | -$62M | -$122.7M | -$17.4M | -$39.3M | |
| Diluted EPS | -$4.51 | -$1.50 | -$2.29 | -$0.34 | -$0.74 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $22.6M | -- | $247.4M | $201.4M | |
| Total Assets | -- | $23.9M | -- | $311.2M | $221.5M | |
| Current Liabilities | -- | $5.1M | -- | $14.7M | $32M | |
| Total Liabilities | -- | $47.4M | -- | $38.6M | $53.8M | |
| Total Equity | -- | -$23.5M | -- | $272.6M | $167.7M | |
| Total Debt | -- | -- | -- | $24.6M | $29.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -$99.2M | -$19.6M | -$25M | |
| Cash From Investing | -- | -- | -$25.1M | -$125.3M | $40.5M | |
| Cash From Financing | -- | -- | $1.5M | $60.2M | $2M | |
| Free Cash Flow | -$25.1M | -- | -$100.7M | -$19.8M | -$25.4M | |
ENGN
Sector
Market Cap
$590.1M
$28.1M
Price % of 52-Week High
79.08%
51.87%
Dividend Yield
0%
0%
Shareholder Yield
-0.96%
-1.59%
1-Year Price Total Return
8.77%
-17.31%
Beta (5-Year)
--
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$8.73
200-day SMA
Buy
Level
$5.49
Bollinger Bands (100)
Buy
Level
5.67 - 8.73
Chaikin Money Flow
Sell
Level
-25.4M
20-day SMA
Buy
Level
$8.63
Relative Strength Index (RSI14)
Buy
Level
54.27
ADX Line
Buy
Level
19.83
Williams %R
Neutral
Level
-58.5034
50-day SMA
Buy
Level
$7.95
MACD (12, 26)
Buy
Level
0.20
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
44.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.917)
Sell
CA Score
(Annual)
Level (-1.0509)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (3.3771)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Stock Forecast FAQ
In the current month, ENGN has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ENGN average analyst price target in the past 3 months is $23.50.
-
Where Will enGene Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that enGene Holdings, Inc. share price will rise to $23.50 per share over the next 12 months.
-
What Do Analysts Say About enGene Holdings, Inc.?
Analysts are divided on their view about enGene Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that enGene Holdings, Inc. is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is enGene Holdings, Inc.'s Price Target?
The price target for enGene Holdings, Inc. over the next 1-year time period is forecast to be $23.50 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ENGN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for enGene Holdings, Inc. is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ENGN?
You can purchase shares of enGene Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase enGene Holdings, Inc. shares.
-
What Is The enGene Holdings, Inc. Share Price Today?
enGene Holdings, Inc. was last trading at $8.76 per share. This represents the most recent stock quote for enGene Holdings, Inc.. Yesterday, enGene Holdings, Inc. closed at $8.81 per share.
-
How To Buy enGene Holdings, Inc. Stock Online?
In order to purchase enGene Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ENGN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ENGN
Sector
P/E ratio
--
24.20x
PEG ratio
-0.07x
-0.01x
P/B ratio
3.52x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
ENGN
Sector
Revenue growth
--
4.51%
Earnings growth
-117.66%
10.7%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.57
-$0.19
Profitability
ENGN
Sector
Profitability FY 2025
-$509K
$3.5M
Return on invested capital
-46.66%
-32.3%
Return on assets
-44.07%
-28.57%
Return on equity
-52.45%
-38.09%
Earnings Date
Last Earnings Date
Jan
11
Next Earnings Date
Jan
11
Estimated Next Earnings Date
Apr
12
Balance Sheet
ENGN
Sector
Total cash
$193.8M
$26M
Short term investments
$65.3M
$25.7M
Total assets
$221.5M
$76.4M
Long term debt
$29.8M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
